Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000414108

Medchemexpress LLC Mivacurium dichloride | 106861-44-3 | 99.0% | 25 MG
SDP

Catalog No. 5000414108
Encompass_Preferred

Mivacurium dichloride is a benzylisoquinoline derivative and a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. It functions by coupling with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the muscle cell's terminal disc.

  • Short-acting non-depolarizing neuromuscular blocking agent.
  • Skeletal muscle relaxant.
  • Functions by inhibiting acetylcholine effects on muscle cells.
  • Induces LAD2 cell degranulation in a dose-dependent manner.
  • Rapid hydrolysis in plasma.
  • Short duration of action (less than 10 minutes).
  • Non-neurological toxicity.
  • Does not alter heart rate.

Catalog No. 50-004-14108 Supplier Medchemexpress LLC Supplier No. 25MGHYB1700A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Mivacurium dichloride is a benzylisoquinoline derivative and a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. It functions by coupling with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the muscle cell's terminal disc.

  • Short-acting non-depolarizing neuromuscular blocking agent.
  • Skeletal muscle relaxant.
  • Functions by inhibiting acetylcholine effects on muscle cells.
  • Induces LAD2 cell degranulation in a dose-dependent manner.
  • Rapid hydrolysis in plasma.
  • Short duration of action (less than 10 minutes).
  • Non-neurological toxicity.
  • Does not alter heart rate.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.